Search research articles
Contact Us
Filters
Showing results (111-120 of 221) with videos related to
Page
of 23
Sort By:
Clinical Lung Cancer
|
December 29, 2023
HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management
Ayse Ece Cali Daylan, Catarina Martins Maia, Shirin Attarian, et al.
JCO Precision Oncology
|
April 7, 2023
Orthogonal Testing Unravels a Novel ROS1 Oncogenic Fusion Variant (<i>ROS1-GPM6A</i>): A Practical Approach to Molecular Testing for Actionable Fusion Variants
Hiba G Narvel, So Yeon Kim, Aspan M Shokrekhuda, et al.
Cancers
|
July 14, 2023
Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways
Feng Wang, Ayse Ece Cali Daylan, Lei Deng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2017
Continuous Activity Monitoring During Concurrent Chemoradiotherapy
Nitin Ohri, Rafi Kabarriti, William R Bodner, et al.
Scientific Reports
|
June 16, 2022
Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
Kunal R Chaudhary, Connor J Kinslow, Haiying Cheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 20, 2024
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up
Shirish M Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2017
Positron Emission Tomography-Adjusted Intensity Modulated Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Nitin Ohri, William R Bodner, Rafi Kabarriti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 24, 2007
Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590
Daniel B Costa, Sigui Li, Olivier Kocher, et al.
Oncotarget
|
December 31, 2015
Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells
Haiying Cheng, Zhenfeng Zhang, Ruth Rodriguez-Barrueco, et al.
Oncology and Therapy
|
July 7, 2017
Efficacy and Safety Results of the Afatinib Expanded Access Program
Edward S Kim, Balazs Halmos, Ingrid F Kohut, et al.
Page
of 23
Search research articles
Search
Showing results (111-120 of 221) with videos related to
Sort By:
Page
of 23
Clinical Lung Cancer
|
December 29, 2023
HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management
Ayse Ece Cali Daylan, Catarina Martins Maia, Shirin Attarian, et al.
JCO Precision Oncology
|
April 7, 2023
Orthogonal Testing Unravels a Novel ROS1 Oncogenic Fusion Variant (<i>ROS1-GPM6A</i>): A Practical Approach to Molecular Testing for Actionable Fusion Variants
Hiba G Narvel, So Yeon Kim, Aspan M Shokrekhuda, et al.
Cancers
|
July 14, 2023
Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways
Feng Wang, Ayse Ece Cali Daylan, Lei Deng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2017
Continuous Activity Monitoring During Concurrent Chemoradiotherapy
Nitin Ohri, Rafi Kabarriti, William R Bodner, et al.
Scientific Reports
|
June 16, 2022
Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
Kunal R Chaudhary, Connor J Kinslow, Haiying Cheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 20, 2024
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up
Shirish M Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 19, 2017
Positron Emission Tomography-Adjusted Intensity Modulated Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Nitin Ohri, William R Bodner, Rafi Kabarriti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 24, 2007
Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590
Daniel B Costa, Sigui Li, Olivier Kocher, et al.
Oncotarget
|
December 31, 2015
Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells
Haiying Cheng, Zhenfeng Zhang, Ruth Rodriguez-Barrueco, et al.
Oncology and Therapy
|
July 7, 2017
Efficacy and Safety Results of the Afatinib Expanded Access Program
Edward S Kim, Balazs Halmos, Ingrid F Kohut, et al.
Page
of 23